Neovacs S.A. (ALNEV) — Cash Flow-to-Debt Ratio
Neovacs S.A. (ALNEV) has a Cash Flow-to-Debt Ratio of -0.63x as of December 2025, meaning its operating cash flow of €-2.60 Million could theoretically repay -1% of its total liabilities (€4.10 Million) in one year. Explore Neovacs S.A. strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Neovacs S.A. Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Neovacs S.A. across 19 annual periods. Also explore total assets of Neovacs S.A. for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Neovacs S.A. (2007–2025)
Year-by-year debt coverage analysis for Neovacs S.A.. For market capitalisation and broader financial context, see Neovacs S.A. stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.23x | €-5.03 Million | €4.10 Million | ▼ -36.6% |
| 2024 | -0.90x | €-3.60 Million | €4.01 Million | ▼ -74.3% |
| 2023 | -0.52x | €-1.91 Million | €3.71 Million | ▲ +41.5% |
| 2022 | -0.88x | €-4.45 Million | €5.05 Million | ▲ +58.7% |
| 2021 | -2.13x | €-9.91 Million | €4.65 Million | ▲ +5.6% |
| 2020 | -2.26x | €-5.65 Million | €2.50 Million | ▼ -33.7% |
| 2019 | -1.69x | €-8.10 Million | €4.80 Million | ▲ +39.1% |
| 2018 | -2.77x | €-13.31 Million | €4.80 Million | ▼ -110.4% |
| 2017 | -1.32x | €-14.26 Million | €10.82 Million | ▲ +3.2% |
| 2016 | -1.36x | €-11.00 Million | €8.08 Million | ▲ +8.2% |
| 2015 | -1.48x | €-7.69 Million | €5.18 Million | ▲ +35.7% |
| 2014 | -2.31x | €-8.05 Million | €3.49 Million | ▼ -38.1% |
| 2013 | -1.67x | €-7.00 Million | €4.19 Million | ▲ +31.6% |
| 2012 | -2.44x | €-6.33 Million | €2.59 Million | ▲ +31.6% |
| 2011 | -3.57x | €-8.63 Million | €2.41 Million | ▼ -6.1% |
| 2010 | -3.37x | €-8.10 Million | €2.40 Million | ▼ -106.6% |
| 2009 | -1.63x | €-7.95 Million | €4.88 Million | ▲ +20.4% |
| 2008 | -2.05x | €-4.49 Million | €2.19 Million | ▲ +3.5% |
| 2007 | -2.12x | €-4.32 Million | €2.04 Million | — |